Total Payments
$11,240
2024 Payments
$1,023
Companies
56
Transactions
943
Medicare Patients
14,601
Medicare Billing
$634,963
Payment Breakdown by Category
Food & Beverage$11,172 (99.4%)
Education$68.07 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,172 | 938 | 99.4% |
| Education | $68.07 | 5 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,043 | 86 | $0 (2024) |
| Amgen Inc. | $999.46 | 102 | $0 (2023) |
| PFIZER INC. | $929.24 | 93 | $0 (2024) |
| Merck Sharp & Dohme LLC | $782.78 | 85 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $755.98 | 29 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $723.70 | 58 | $0 (2024) |
| ABBVIE INC. | $722.55 | 62 | $0 (2024) |
| Lilly USA, LLC | $634.56 | 65 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $443.85 | 36 | $0 (2023) |
| GlaxoSmithKline, LLC. | $414.47 | 55 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,023 | 46 | AIMMUNE THERAPEUTICS, INC. ($255.66) |
| 2023 | $1,494 | 110 | ABBVIE INC. ($233.81) |
| 2022 | $1,615 | 137 | ABBVIE INC. ($179.12) |
| 2021 | $1,815 | 161 | AbbVie Inc. ($212.19) |
| 2020 | $1,139 | 99 | Amgen Inc. ($221.91) |
| 2019 | $1,568 | 143 | Novo Nordisk Inc ($198.22) |
| 2018 | $1,096 | 104 | PFIZER INC. ($155.56) |
| 2017 | $1,489 | 143 | Merck Sharp & Dohme Corporation ($217.99) |
All Payment Transactions
943 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE, TRADJENTA | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: DIABETES | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.92 | General |
| 06/24/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: PAIN | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.37 | General |
| 06/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: NEUROSCIENCE | ||||||
| 06/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Biological | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Obesity | ||||||
| 05/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: DIABETES | ||||||
| 05/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: PAIN | ||||||
| 05/14/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Endocrinology | ||||||
| 05/12/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $255.66 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.47 | General |
| 05/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Obesity | ||||||
| 05/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Biological | ||||||
| 04/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: VACCINES | ||||||
| 04/21/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Endocrinology | ||||||
| 04/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Cardio-renal | ||||||
| 04/04/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: VACCINE | ||||||
| 04/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: DIABETES | ||||||
| 03/29/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: Iron Deficiency Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 3,082 | 7,327 | $427,018 | $115,942 |
| 2022 | 38 | 3,634 | 8,503 | $483,961 | $129,643 |
| 2021 | 40 | 4,123 | 9,428 | $563,693 | $214,092 |
| 2020 | 38 | 3,762 | 8,459 | $506,944 | $175,285 |
Total Patients
14,601
Total Services
33,717
Medicare Billing
$634,963
Procedure Codes
149
All Medicare Procedures & Services
149 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 24 | 2,220 | $74,760 | $37,991 | 50.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 297 | 788 | $209,924 | $31,564 | 15.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 239 | 384 | $14,208 | $4,943 | 34.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 278 | 606 | $5,916 | $4,819 | 81.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 207 | 262 | $9,956 | $4,313 | 43.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 241 | 415 | $12,035 | $4,268 | 35.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 257 | 447 | $9,387 | $3,353 | 35.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 169 | 169 | $3,380 | $2,870 | 84.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 62 | $11,558 | $2,459 | 21.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 97 | 240 | $6,000 | $2,150 | 35.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 72 | 74 | $4,952 | $2,100 | 42.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 58 | 60 | $4,860 | $1,683 | 34.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 75 | 77 | $2,414 | $1,614 | 66.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 78 | 80 | $3,600 | $1,409 | 39.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 63 | 156 | $10,424 | $1,359 | 13.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 50 | 58 | $4,982 | $1,149 | 23.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 29 | $10,726 | $1,008 | 9.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 16 | 16 | $4,544 | $992.48 | 21.8% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 157 | 160 | $1,920 | $948.40 | 49.4% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 157 | 160 | $2,240 | $788.56 | 35.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 16 | $8,326 | $645.74 | 7.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 14 | 14 | $1,092 | $582.02 | 53.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 128 | 180 | $1,620 | $535.54 | 33.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 156 | 223 | $1,115 | $479.00 | 43.0% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 15 | 60 | $1,740 | $449.97 | 25.9% |
About Dr. Michael Hattan, MD
Dr. Michael Hattan, MD is a Family Medicine healthcare provider based in South Sioux City, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124093232.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Hattan, MD has received a total of $11,240 in payments from pharmaceutical and medical device companies, with $1,023 received in 2024. These payments were reported across 943 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($11,172).
As a Medicare-enrolled provider, Hattan has provided services to 14,601 Medicare beneficiaries, totaling 33,717 services with total Medicare billing of $634,963. Data is available for 4 years (2020–2023), covering 149 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location South Sioux City, NE
- Active Since 02/22/2006
- Last Updated 03/08/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1124093232
Products in Payments
- FARXIGA (Drug) $612.74
- JARDIANCE (Drug) $471.69
- ELIQUIS (Drug) $429.25
- VRAYLAR (Drug) $405.93
- Ozempic (Drug) $369.11
- UBRELVY (Drug) $327.55
- Aimovig (Biological) $323.87
- EVENITY (Biological) $301.04
- Kerendia (Drug) $300.66
- JANUVIA (Drug) $273.62
- ZENPEP (Drug) $271.12
- Rybelsus (Drug) $231.16
- NEXLETOL (Drug) $228.94
- MOUNJARO (Drug) $216.36
- Prolia (Biological) $215.91
- Vascepa (Drug) $207.42
- CHANTIX (Drug) $194.13
- Tymlos (Biological) $193.42
- VYVANSE (Drug) $183.06
- Tresiba (Drug) $177.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in South Sioux City
Dr. Michael Brenner, M.d, M.D
Family Medicine — Payments: $17,646
Family Medicine $17,646
Thomas Wente, Do, DO
Family Medicine — Payments: $10,128
Family Medicine $10,128
Melissa Austreim-Krell, M.d, M.D
Family Medicine — Payments: $8,652
Family Medicine $8,652
David Ensz, M.d, M.D
Family Medicine — Payments: $7,676
Family Medicine $7,676
Suhair Najdawi, Md, MD
Family Medicine — Payments: $4,040
Family Medicine $4,040
Austin Granatowicz, Md, MD
Family Medicine — Payments: $2,343
Family Medicine $2,343